Investors Embrace Synthetic Biology Despite Concerns – Chem.Info
|
Investors Embrace Synthetic Biology Despite Concerns
Chem.Info Investors are increasingly convinced that the chemical, pharmaceutical and cosmetics industries are close to capitalizing on recent breakthroughs in biology. But their enthusiasm could be tempered by hesitancy on the part of the public and regulators … |
